The legalization of marijuana is often considered to be a model for psychedelics. Thus far, marijuana has been legalized for both medical and recreational use in various nations across the globe and in numerous states in the United States.
From the above, one can deduce that there are two primary ways to end the ban on psychedelics: decriminalization or medicalization. However, while those two options are effective, they conceal another way of using psychedelics: obtaining legal sanction for the religious or spiritual use of psychedelics that are considered sacred tools for holy rituals in various traditions.
Here, we are referring to established religions that have long-used psychedelics, not the recently formed psilocybin or cannabis churches. Members of Abrahamic faiths have slowly began including entheogens into their practices, citing various Biblical traditions as their precedent. Entheogens are substances that bring about spiritual experiences.
A good example of this would be a group managed by Adriana Kertzer, the founding partner of Plant Medicine Laws Group, which has grown their membership in under six months. Known as Faith+ Delics, the meet-up group has drawn in practitioners of Christianity, Islam and Judaism, as well as scholars, priests and rabbis.
Scholars note Christ’s holy anointing oil kaneh-bosm (cannabis) and point to the use of acacia wood, which is said to contain DMT and a mixture of other entheogens that were used in Israeli incense rituals, with more archeological evidence demonstrating the presence of marijuana residue at holy biblical sites in Israel’s ancient city of Tel Arad.
Despite this evidence, however, many speculate whether going after the religious protection of psychedelics may be another way to end prohibition. This is mainly because it hasn’t been clearly defined by law whether a psychedelic can be utilized in a religious ceremony legally. This is, of course, with the exclusion of the religious exemptions offered to Santo Daime and Uniao do Vegetal (“UDV”) churches to utilize ayahuasca and the Native American Church (“NAC”) to utilize peyote.
In addition, the churches mentioned above have Christian elements, which make the likelihood of them obtaining exemptions far more likely, as they are based on an already established religion.
Furthermore, newly established religions may be required to demonstrate some level of established traditions and practice using entheogens and may from time to time require rulings from religious leaders, which isn’t as easy as basing entheogenic practices on religions that are already well established.
Despite these challenges, the incorporation of psychedelics into Abrahamic religious practices may become easier to defend as more evidence that psychedelics are necessary and central continues to surface; this could just be another way to get these substances into the mainstream.
While the spiritual dimension to the use of psychedelics in ancient times is explored, a number of companies such as XPhyto Therapeutic Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are looking to develop medicinal formulations that can obtain regulatory approval for use by patients.
NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire is part of the InvestorBrandNetwork.